154 related articles for article (PubMed ID: 15281116)
1. Purification of antibody and antibody-fragment from E. coli homogenate using 6,9-diamino-2-ethoxyacridine lactate as precipitation agent.
Persson J; Lester P
Biotechnol Bioeng; 2004 Aug; 87(3):424-34. PubMed ID: 15281116
[TBL] [Abstract][Full Text] [Related]
2. [High level expression of chimeric antibody fragment F(ab')2 directed against CD20 in Escherichia coli].
Xiong DS; Zheng MJ; Liu YX; Xu YF; Wang JH; Yang CZ
Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):673-8. PubMed ID: 15973988
[TBL] [Abstract][Full Text] [Related]
3. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.
Rodrigues ML; Snedecor B; Chen C; Wong WL; Garg S; Blank GS; Maneval D; Carter P
J Immunol; 1993 Dec; 151(12):6954-61. PubMed ID: 7903100
[TBL] [Abstract][Full Text] [Related]
4. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
Cheung GL; Thomas TM; Rylatt DB
Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
[TBL] [Abstract][Full Text] [Related]
5. Use of thiophilic adsorption chromatography for the one-step purification of a bacterially produced antibody F(ab) fragment without the need for an affinity tag.
Fiedler M; Skerra A
Protein Expr Purif; 1999 Dec; 17(3):421-7. PubMed ID: 10600461
[TBL] [Abstract][Full Text] [Related]
6. Rapid two-step purification of a recombinant mouse Fab fragment expressed in Escherichia coli.
Wlad H; Ballagi A; Bouakaz L; Gu Z; Janson JC
Protein Expr Purif; 2001 Jul; 22(2):325-9. PubMed ID: 11437609
[TBL] [Abstract][Full Text] [Related]
7. Engineering of Escherichia coli to improve the purification of periplasmic Fab' fragments: changing the pI of the chromosomally encoded PhoS/PstS protein.
Humphreys DP; Heywood SP; King LM; Bowering LC; Turner JP; Lane SE
Protein Expr Purif; 2004 Sep; 37(1):109-18. PubMed ID: 15294288
[TBL] [Abstract][Full Text] [Related]
8. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
9. Covalent modifications of antitetanus F(ab')2 fragments with natural and synthetic polyamines and their effects on the antibody endocytosis in cultured HL60 cells.
Hervé F; Ghinea N; D'Athis P; Carrupt PA; Scherrmann JM
Bioconjug Chem; 2008 Aug; 19(8):1543-55. PubMed ID: 18630939
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic purification of equine immunoglobulin G F(ab)2 from plasma.
Fernandes A; Kaundinya JO; Daftary G; Saxena L; Banerjee S; Pattnaik P
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):109-15. PubMed ID: 19008160
[TBL] [Abstract][Full Text] [Related]
11. Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
Seddik SS; Wanas S; Shehata A; Fawaz S; Helmy MH
J Nat Toxins; 2002 May; 11(2):123-32. PubMed ID: 12009112
[TBL] [Abstract][Full Text] [Related]
12. Rapid screening of purification strategies for the capture of a human recombinant F(ab')2 expressed in baculovirus-infected cells using a micro-plate approach and SELDI-MS.
Pezzini J; Brenac Brochier V; Barrouillet MP; Cerruti M; Clofent-Sanchez G; Schapman A; Topol A; Robert R; Cabanne C; Cerruti P; Santarelli X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2428-34. PubMed ID: 19467934
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
14. Thiopropyl-agarose as a solid phase reducing agent for chemical modification of IgG and F(ab')2.
Ferraz N; Leverrier J; Batista-Viera F; Manta C
Biotechnol Prog; 2008; 24(5):1154-9. PubMed ID: 19194926
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a recombinant intracellular beta-galactosidase by ammonium sulfate fractionation of cell homogenates.
Zhang Z; Chisti Y; Moo-Young M
Bioseparation; 1995; 5(6):329-37. PubMed ID: 8767926
[TBL] [Abstract][Full Text] [Related]
16. Purification of recombinant chimeric B72.3 Fab' and F(ab')2 using streptococcal protein G.
Proudfoot KA; Torrance C; Lawson AD; King DJ
Protein Expr Purif; 1992 Oct; 3(5):368-73. PubMed ID: 1458050
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
Lutz HU; Fumia S
Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
[TBL] [Abstract][Full Text] [Related]
18. Structural effect of a recombinant monoclonal antibody on hinge region peptide bond hydrolysis.
Xiang T; Lundell E; Sun Z; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):254-62. PubMed ID: 17901002
[TBL] [Abstract][Full Text] [Related]
19. Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.
Fumia S; Goede JS; Fischler M; Luginbühl A; Frick S; Fodor P; Lutz HU
Mol Immunol; 2008 May; 45(10):2951-61. PubMed ID: 18339427
[TBL] [Abstract][Full Text] [Related]
20. [Production of highly purified therapeutic immunoglobulins (HPTI): analysis of a purification process].
Nguyen L
Biol Aujourdhui; 2010; 204(1):55-9. PubMed ID: 20950576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
